Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

NCT02322320 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

273

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]
[object Object]
[object Object]